|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Emerging Infectious Diseases
|
NIMH
|
5R01MH072556-03
|
|
The STIRR Intervention for Dually Diagnosed Clients
|
ROSENBERG, STANLEY
|
DARTMOUTH COLLEGE
|
NH
|
$553,218
|
|
Emerging Infectious Diseases
|
NIAID
|
1R43AI073266-01
|
|
Printed Disposable Sensor for Quantitative HIV RNA Measurement of Viral Load
|
HENKENS, ROBERT
|
ALDERON BIOSCIENCES, INC.
|
NC
|
$141,240
|
|
Emerging Infectious Diseases
|
NIDA
|
1K23DA020383-01A1
|
|
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users
|
TAYLOR, LYNN
|
MIRIAM HOSPITAL
|
RI
|
$179,212
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM063879-06
|
|
Expression of Human Therapeutic Proteins in Transgenic Tobacco Chloroplasts
|
DANIELL, HENRY
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$281,384
|
|
Emerging Infectious Diseases
|
NHLBI
|
4R37HL071544-06
|
|
Mechanism of Staphylocoagulase-activated Blood Clotting
|
BOCK, PAUL
|
VANDERBILT UNIVERSITY
|
TN
|
$345,375
|
|
Emerging Infectious Diseases
|
NIAID
|
4R37AI016935-24
|
|
Iron transport in Shigella and pathogenic E.coli
|
PAYNE, SHELLEY
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$371,500
|
|
Emerging Infectious Diseases
|
NIDA
|
5R01DA016188-06
|
|
Male IDUs in Viet Nam: Ethno-Epidemiology of HIV Risk
|
CLATTS, MICHAEL
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
PR
|
$542,951
|
|
Emerging Infectious Diseases
|
NIAID
|
5U01AI066327-04
|
|
Rationally designed Rift Valley Fever Virus Vaccine
|
FLICK, RAMON
|
BIOPROTECTION SYSTEMS CORPORATION
|
IA
|
$462,742
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM072778-03
|
|
A Prion Reveals Complex Traits and Phenotypic Diversity
|
TRUE-KROB, HEATHER
|
WASHINGTON UNIVERSITY
|
MO
|
$291,339
|
|
Emerging Infectious Diseases
|
NIDA
|
1R01DA021550-01A2
|
|
HCV Transmission among Young IDUs in NYC
|
EDLIN, BRIAN
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$834,452
|
|
Emerging Infectious Diseases
|
NIAID
|
1K22AI074662-01
|
|
Influenza Viral RNA Synthesis and Processing
|
NEWCOMB, LAURA
|
CALIFORNIA STATE UNIV SAN BERNARDINO
|
CA
|
$160,000
|
|
Emerging Infectious Diseases
|
NIAID
|
1K22AI074908-01
|
|
Role of endosomal cysteine protease in Ebola and Marburg virus entry
|
CHANDRAN, KARTIK
|
YESHIVA UNIVERSITY
|
NY
|
$160,440
|
|
Emerging Infectious Diseases
|
NIDCD
|
5R01DC006452-03
|
|
Effect of the Middle Ear Inflammation On the Inner Ear
|
JUHN, STEVEN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$304,466
|
|
Emerging Infectious Diseases
|
NIAID
|
2R01AI053067-06
|
|
Quorum sensing regulation of EHEC virulence genes
|
SPERANDIO, VANESSA
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$451,461
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM060620-09
|
|
Mechanism of RNA Helicase Activity by DExH/D Proteins
|
PYLE, ANNA
|
YALE UNIVERSITY
|
CT
|
$239,995
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI055358-05
|
|
Regulation of Macrophage Cell Death by Toxoplasma gondii
|
ORLOFSKY, AMOS
|
YESHIVA UNIVERSITY
|
NY
|
$388,343
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM026796-25
|
|
Mechanism of Protein Synthesis Initiation
|
MERRICK, WILLIAM
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$364,543
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM031186-25
|
|
Enzymatic Mechanisms of Sulfur Nucleoside Metabolism
|
MARKHAM, GEORGE
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$381,378
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064616-03
|
|
The Role of Toxoplasma Rhoptries in Host Cell Infection
|
BRADLEY, PETER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$323,656
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI033537-15
|
|
Virulence Gene Expression by Bacillus anthracis
|
KOEHLER, THERESA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$239,055
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059327-05
|
|
Synthesis and Mechanistic Studies of Peptide Antibiotics
|
VANNIEUWENHZE, MICHAEL
|
INDIANA UNIVERSITY BLOOMINGTON
|
IN
|
$304,603
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059415-04
|
|
Endotoxin Exposure Alters-Anti-Tetanus IgE in Infants
|
OWNBY, DENNIS
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$348,515
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI042135-11
|
|
TNF Mediated Immune Defense Against Listeria Infection
|
PAMER, ERIC
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$430,201
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI047365-09
|
|
Structure and Function of the Hepatitis C Virus Genome
|
SARNOW, PETER
|
STANFORD UNIVERSITY
|
CA
|
$362,764
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI063402-04
|
|
IDO dependent T cell suppression
|
MELLOR, ANDREW
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$266,027
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI055268-05
|
|
IMPDH as a Drug Target in Cryptosporidium
|
STRIEPEN, BORIS
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$298,836
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM031847-25
|
|
Hydrogen exchange, proteins, folding, and misfolding
|
ENGLANDER, S.
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$369,812
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064738-03
|
|
RNAi as an Intercellular Antiviral Defense Mechanism
|
ANDINO, RAUL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$319,446
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064671-03
|
|
Biology of the Apicomplexan Plastid
|
STRIEPEN, BORIS
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$280,431
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059614-04
|
|
Production of Antibodies in Algae for Biodefense
|
MAYFIELD, STEPHEN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$396,601
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI068056-03
|
|
Generation and maintenance of influenza-specific plasma and memory B cells
|
LUND, FRANCES
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$375,067
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057460-05
|
|
Group 1 CD1 in Infectious Disease and T Cell Development
|
WANG, CHYUNG-RU
|
UNIVERSITY OF CHICAGO
|
IL
|
$46,390
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI049301-07
|
|
How do you build a parasite?
|
MURRAY, JOHN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$361,918
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI049361-05
|
|
The role of Notch signaling in T cell function
|
OSBORNE, BARBARA
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$321,684
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI063230-04
|
|
Functional Analysis of Cu/Zn Superoxide Dismutase
|
SLAUCH, JAMES
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$338,953
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI042797-11
|
|
Targeting of Yop Proteins by Yersinia enterocolitica
|
SCHNEEWIND, OLAF
|
UNIVERSITY OF CHICAGO
|
IL
|
$306,506
|
|
Emerging Infectious Diseases
|
NIMH
|
5R01MH067990-05
|
|
Fronto-Striatal Dysfunction in IFNa-Induced Depression
|
MILLER, ANDREW
|
EMORY UNIVERSITY
|
GA
|
$261,130
|
|
Emerging Infectious Diseases
|
NIMH
|
5K05MH069124-05
|
|
Pathology and Treatment of Cytokine-Induced Depression
|
MILLER, ANDREW
|
EMORY UNIVERSITY
|
GA
|
$116,932
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059406-04
|
|
SHIP-2 influence on macrophage Fc receptor function
|
TRIDANDAPANI, SUSHEELA
|
OHIO STATE UNIVERSITY
|
OH
|
$278,119
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI060761-03
|
|
Arabidopsis basal innate immunity to bacterial infection
|
HE, SHENG
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$347,413
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM052216-12
|
|
Arsenate resistance in prokaryotes and eukaryotes
|
ROSEN, BARRY
|
WAYNE STATE UNIVERSITY
|
MI
|
$227,147
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI032178-15
|
|
Plasmid-Mediated Virulence in Salmonella
|
GUINEY, DONALD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$353,462
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM036387-19
|
|
Regulation of Caspase-1 Signaling and Inflammation by the P2X7 ATP Receptor
|
DUBYAK, GEORGE
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$355,350
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI042792-09
|
|
Tick-Mammal Interface of Human Granulocytic Anaplasmosis
|
MUNDERLOH, ULRIKE
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$513,217
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059650-05
|
|
Host response to Chlamydia genital infection in the male
|
RANK, ROGER
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
AR
|
$332,534
|
|
Emerging Infectious Diseases
|
NIAID
|
1R43AI075645-01
|
|
Pseudo Target Amplification Diagnostics
|
HENKENS, ROBERT
|
ALDERON BIOSCIENCES, INC.
|
NC
|
$141,240
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI039614-12
|
|
Tracking CD4+ Memory T Cells in Vivo
|
JENKINS, MARC
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$349,557
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059533-04
|
|
T cell immune response to group A streptococci in NALT
|
CLEARY, PAUL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$273,089
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI035726-13
|
|
Class II MHC Transport and Function
|
HARDING, CLIFFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$367,923
|
|
Emerging Infectious Diseases
|
NIDDK
|
5R01DK047343-14
|
|
Role of Substance P in Intestinal Inflammation
|
POTHOULAKIS, CHARALABOS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$336,285
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI043356-10
|
|
sar-mediated regulation in Staphylococcus aureus
|
SMELTZER, MARK
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$264,167
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI035817-14
|
|
Mechanism and function of unipolarity of Shigella IcsA
|
GOLDBERG, MARCIA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$406,520
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057591-04
|
|
Alteration of innate immunity by HCV core
|
HAHN, YOUNG
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$282,356
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI045053-08
|
|
Recognition of bacterial antigens by NKT cells
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$361,588
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI058054-05
|
|
Molecular Evolution of Eukaryotes: a protistan emphasis
|
SOGIN, MITCHELL
|
MARINE BIOLOGICAL LABORATORY
|
MA
|
$532,619
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI056070-04
|
|
Antibody Protection in Histoplamosis
|
NOSANCHUK, JOSHUA
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064831-03
|
|
Malaria: Immunity and Diversity in Low Transmission
|
BRANCH, ORALEE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$389,480
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM049076-13
|
|
Chemical Models of Protein beta-Sheet Interactions
|
NOWICK, JAMES
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$252,598
|
|
Emerging Infectious Diseases
|
NIAID
|
1R01AI075452-01
|
|
Transmission dynamics of cryptosporidial infections in India
|
KANG, GAGANDEEP
|
CHRISTIAN MEDICAL COLLEGE
|
INDIA
|
$81,000
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057870-05
|
|
CHARACTERIZATION OF ANTHRAX TOXIN RECEPTOR INTERACTIONS
|
BRADLEY, KENNETH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$319,442
|
|
Emerging Infectious Diseases
|
NIAID
|
5U01AI061246-04
|
|
DNA Minor Groove-binding Drugs and Food-borne Pathogens
|
PERRELLA, MARK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$408,264
|
|
Emerging Infectious Diseases
|
NCI
|
5R01CA124621-02
|
|
Role of Arsenic Trioxide in Primary Effusion Lymphoma
|
CHAUDHARY, PREET
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$278,353
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI048496-07
|
|
Improved Brucella Vaccine Strains
|
FICHT, THOMAS
|
TEXAS AGRILIFE RESEARCH
|
TX
|
$346,491
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM055769-09
|
|
NMR Studies of Bacterial Regulatory Proteins
|
CAVANAGH, JOHN
|
NORTH CAROLINA STATE UNIVERSITY RALEIGH
|
NC
|
$213,396
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059523-04
|
|
Orgin of multidrug resistant uropathogenic E. coli
|
RILEY, LEE
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$282,770
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI043987-10
|
|
Type II Secretion and Legionella pneumophila Infection
|
CIANCIOTTO, NICHOLAS
|
NORTHWESTERN UNIVERSITY
|
IL
|
$239,471
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI062832-04
|
|
Immunity to Intracellular Pathogens
|
UNANUE, EMIL
|
WASHINGTON UNIVERSITY
|
MO
|
$355,788
|
|
Emerging Infectious Diseases
|
NIAID
|
5R37AI047367-09
|
|
HCV-specific T cell response
|
WALKER, CHRISTOPHER
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$541,702
|
|
Emerging Infectious Diseases
|
NIAID
|
7R01AI058107-04
|
|
PRIMATE MODEL AND PATHOGENESIS OF ANTHRAX SEPSIS
|
KUROSAWA, SHINICHIRO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$487,215
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI055352-05
|
|
Novel Antimicrobial Agents Against M. tuberculosis
|
HORWITZ, MARCUS
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$454,104
|
|
Emerging Infectious Diseases
|
NIA
|
5F32AG027641-03
|
|
Enhancing Aged CD4+ T Cell Immunity to Influenza
|
JONES, STEPHEN
|
TRUDEAU INSTITUTE, INC.
|
NY
|
$24,853
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI060753-03
|
|
Nasal carriage of S. aureus: host-pathogen interactions
|
COLE, ALEXANDER
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$306,483
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI054476-05
|
|
TYPE IV SECRETION & SIGNAL TRANSDUCTION IN EHRLICHIOSIS
|
RIKIHISA, YASUKO
|
OHIO STATE UNIVERSITY
|
OH
|
$347,649
|
|
Emerging Infectious Diseases
|
NIDCD
|
5R01DC008600-02
|
|
Molecular Biology of the Odorant Receptors
|
VOSSHALL, LESLIE
|
ROCKEFELLER UNIVERSITY
|
NY
|
$319,011
|
|
Emerging Infectious Diseases
|
NIDDK
|
5F32DK067781-03
|
|
Cis- and Trans-acting Factors in HCV Gene Expression
|
BRADRICK, SHELTON
|
DUKE UNIVERSITY
|
NC
|
$52,048
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI068715-02
|
|
Characterization of a novel AB5 cytotoxin
|
PATON, ADRIENNE
|
UNIVERSITY OF ADELAIDE
|
AUSTRA
|
$264,871
|
|
Emerging Infectious Diseases
|
NIMH
|
5R01MH079752-02
|
|
Role of evolving white matter damage in neurocognitive effects of HIV and HCV
|
JERNIGAN, TERRY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$347,625
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI072732-03
|
|
Inhibition of Anthrax Lethal Factor by alpha-defensins
|
LU, WUYUAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$367,875
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI063516-03
|
|
Brucella Iron Metabolism in Host Macrophages
|
ROOP, ROY
|
EAST CAROLINA UNIVERSITY
|
NC
|
$305,412
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI044005-10
|
|
Antigenic variation in rickettsial transmission
|
PALMER, GUY
|
WASHINGTON STATE UNIVERSITY
|
WA
|
$273,096
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065529-02
|
|
Regulatory Networks of Helicobacter pylori
|
MERRELL, D
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$374,742
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI072661-02
|
|
Structural Analysis of Vibrio cholerae Virulence Gene Regulatory Proteins
|
KULL, F
|
DARTMOUTH COLLEGE
|
NH
|
$392,155
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI054423-05
|
|
Genetic requirements of Helicobacter pylori infection
|
SALAMA, NINA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$356,805
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI035705-15
|
|
Staphylococcal methicillin resistance locus
|
ARCHER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$489,096
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064705-03
|
|
Viral recognition by plasmacytoid dendritic cell
|
IWASAKI, AKIKO
|
YALE UNIVERSITY
|
CT
|
$389,355
|
|
Emerging Infectious Diseases
|
NCI
|
5R01CA082036-09
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$443,347
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI036525-11
|
|
Immune Mechanisms of Protection in S Typhi Vaccines
|
SZTEIN, MARCELO
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$439,396
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI041014-11
|
|
Developmental Biology of Toxoplasma
|
BOOTHROYD, JOHN
|
STANFORD UNIVERSITY
|
CA
|
$344,307
|
|
Emerging Infectious Diseases
|
NIAID
|
1R13AI075719-01
|
|
International Congress of Virology, Istanbul, ASV Travel Request
|
SAWICKI, DOROTHEA
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$30,000
|
|
Emerging Infectious Diseases
|
NIAID
|
2P01AI053725-06
|
0006
|
Glycolipid Specific T Cell Responses
|
BENDELAC, ALBERT
|
UNIVERSITY OF CHICAGO
|
IL
|
$274,926
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI048849-07
|
|
MHC Class I Antigen Presentation in Viral Infections
|
SIGAL, LUIS
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$419,378
|
|
Emerging Infectious Diseases
|
NIAID
|
5R44AI056944-05
|
|
Antibody-Biocide Fusions to Control Cryptosporidium
|
IMBODEN, MICHAEL
|
IOGENETICS, LLC
|
WI
|
$1,151,226
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI046433-09
|
|
Protease and ROP Genes in S Pyogenes Virulence
|
CAPARON, MICHAEL
|
WASHINGTON UNIVERSITY
|
MO
|
$320,211
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI072479-02
|
|
Analysis of gene regulation of Vibrio cholerae infection
|
ZHU, JUN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$379,502
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI072613-02
|
|
Identification and characterization of cellular factors involved in HCV entry
|
RICE, CHARLES
|
ROCKEFELLER UNIVERSITY
|
NY
|
$414,473
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI070863-02
|
|
SCREEN DEVELOPMENT FOR ANTIMICROBIAL PRODRUGS
|
LEWIS, KIM
|
NORTHEASTERN UNIVERSITY
|
MA
|
$385,043
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI039454-12
|
|
Toxoplasma encephalitis in AIDS: Bradyzoite Regulation
|
WEISS, LOUIS
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM057045-11
|
|
Forespore Engulfment During B subtilis Sporulation
|
POGLIANO, KIT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$320,412
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM052190-14
|
|
Organic Nanotubes Design and Biological Applications
|
GHADIRI, M.
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$414,010
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI072508-02
|
|
Novel whole-animal screens for anti-microbials
|
AUSUBEL, FREDERICK
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$415,454
|
|
Emerging Infectious Diseases
|
NHLBI
|
5R01HL076586-04
|
|
Structure-Function Relationships in Lung Surfactants
|
LONG, JOANNA
|
UNIVERSITY OF FLORIDA
|
FL
|
$272,254
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI044238-10
|
|
Species-specific regulated transposition in mosquitoes
|
JAMES, ANTHONY
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$351,413
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI066058-02
|
|
Legionella pneumophila developmental cycle & virulence
|
HOFFMAN, PAUL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$370,162
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI042015-10
|
|
Regulation of the (poly) sialic virulence factor
|
VIMR, ERIC
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$177,895
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059176-05
|
|
Infectivity and Transmission of Toxoplasmosis
|
SIBLEY, L
|
WASHINGTON UNIVERSITY
|
MO
|
$355,788
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM063270-08
|
|
Mathematical models of H. pylori gastric colonization
|
BLASER, MARTIN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$256,013
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057637-04
|
|
Clostridium difficile Toxin Gene Regulation
|
SONENSHEIN, ABRAHAM
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$265,401
|
|
Emerging Infectious Diseases
|
NHLBI
|
5R01HL078860-03
|
|
Role of Epithelium in Immunity, Inflammation and Disease
|
SCHLEIMER, ROBERT
|
NORTHWESTERN UNIVERSITY
|
IL
|
$366,553
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI039657-12
|
|
Structure-function analysis of H. pylori VacA
|
COVER, TIMOTHY
|
VANDERBILT UNIVERSITY
|
TN
|
$346,156
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI045764-08
|
|
IMMUNE POTENTIAL OF ANIMAL LACKING CLASS IA MOLECULES
|
FORMAN, JAMES
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$333,563
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI032042-15
|
|
Methods for Evaluating Vaccine Efficacy
|
HALLORAN, M
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$438,180
|
|
Emerging Infectious Diseases
|
NIDDK
|
5R01DK073902-03
|
|
Mechanism that regulate Helicobacter pylori-induced beta-caterin activation
|
PEEK, RICHARD
|
VANDERBILT UNIVERSITY
|
TN
|
$290,565
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI046985-08
|
|
Serine Proteinases in Apicomplexan Parasites
|
KIM, KAMI
|
YESHIVA UNIVERSITY
|
NY
|
$347,418
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI055743-06
|
|
CD4 T Cell Response to Salmonella
|
MCSORLEY, STEPHEN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$320,414
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064389-04
|
|
Identification of New Antigens for a Plague Vaccine
|
CHOPRA, ASHOK
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$351,137
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065985-03
|
|
Defining NS4B Function in Hepatitis C Virus Replication
|
BLIGHT, KERIL
|
WASHINGTON UNIVERSITY
|
MO
|
$289,575
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069296-02
|
|
Indirect recognition of microbes by NKT cells
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$419,157
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI048825-08
|
|
Synthesis of Antibiotics
|
MYERS, ANDREW
|
HARVARD UNIVERSITY
|
MA
|
$312,436
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069313-03
|
|
Bacterial cell killing by topoisomerase I mediated DNA lesion
|
TSE-DINH, YUK-CHING
|
NEW YORK MEDICAL COLLEGE
|
NY
|
$371,495
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI031940-18
|
|
Genetic Analysis of Cholera Toxin Structure and Function
|
HOLMES, RANDALL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$562,026
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI035237-13
|
|
Nramp1 in macrophage defences against infections
|
GROS, PHILIPPE
|
MCGILL UNIVERSITY
|
CANADA
|
$175,801
|
|
Emerging Infectious Diseases
|
NIAID
|
1R13AI075924-01
|
|
2008 Spirochetes Gordon Research Conference
|
HAAKE, DAVID
|
GORDON RESEARCH CONFERENCES
|
RI
|
$15,000
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057576-05
|
|
Mechanism and Spread of Qnr-Mediated Resistance
|
HOOPER, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$203,474
|
|
Emerging Infectious Diseases
|
NIDDK
|
5R01DK064223-05
|
|
HCV NS5A: Molecular Virology and Antiviral Target
|
GLENN, JEFFREY
|
STANFORD UNIVERSITY
|
CA
|
$261,667
|
|
Emerging Infectious Diseases
|
NIAID
|
5U01AI061286-04
|
|
HRF, an NFkB antagonist targeting multiple pathogenes
|
SIMM, MALGORZATA
|
ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS
|
NY
|
$296,367
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069227-02
|
|
Surface Proteins and Sortases of Bacillus anthracis
|
SCHNEEWIND, OLAF
|
UNIVERSITY OF CHICAGO
|
IL
|
$366,382
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI066121-02
|
|
IFNalphaBeta-Dependent and-Independent TLR/CD40 Synergy
|
KEDL, ROSS
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$377,685
|
|
Emerging Infectious Diseases
|
NIDDK
|
5R01DK062185-06
|
|
H.pylori Effects on DNA Repair in Gastric Epithelium
|
SEPULVEDA, ANTONIA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$180,013
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI060991-03
|
|
Genetic control of immune response to Listeria infection
|
BOYARTCHUK, VICTOR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$348,277
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI043521-11
|
|
Salmonella Antimicrobial Peptide Resistance
|
GUNN, JOHN
|
OHIO STATE UNIVERSITY
|
OH
|
$278,119
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI050073-07
|
|
Regulation of T cell homeostasis by IFN-gamma
|
HARTY, JOHN
|
UNIVERSITY OF IOWA
|
IA
|
$361,744
|
|
Emerging Infectious Diseases
|
NIAID
|
5R37AI030048-17
|
|
T CELL MEMORY TO VIRUSES
|
AHMED, RAFI
|
EMORY UNIVERSITY
|
GA
|
$429,930
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI067861-03
|
|
Importance of adhesin-like proteins of Enteroccocus faecium
|
MURRAY, BARBARA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$353,635
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM055387-12
|
|
Enzymology of RNA Processing Enzymes
|
FIERKE, CAROL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$255,396
|
|
Emerging Infectious Diseases
|
NIMH
|
5R01MH070553-04
|
|
Cytokine-CRH Interactions in IFN-alfa-Induced Depression
|
RAISON, CHARLES
|
EMORY UNIVERSITY
|
GA
|
$326,412
|
|
Emerging Infectious Diseases
|
NIMH
|
5R01MH067978-05
|
|
Maternal Viral Infection and Fetal Brain Development
|
PATTERSON, PAUL
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
CA
|
$307,210
|
|
Emerging Infectious Diseases
|
NIAID
|
5U01AI061260-04
|
|
VSV as a vector for cytokine-assisted tularemia vaccines
|
MILLER, MARK
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$582,057
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI054580-05
|
|
A new family of secreted adhesive proteins in Plasmodium
|
TEMPLETON, THOMAS
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$312,535
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM027068-29
|
|
Genetic Analysis of Bacterial Chromosome Structure
|
ROTH, JOHN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$468,713
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065539-03
|
|
Campylobacter jejuni flagellar regulation and synthesis
|
HENDRIXSON, DAVID
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$336,489
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI044639-08
|
|
Targetting InhA For Anti-TB Drug Discovery
|
TONGE, PETER
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$205,756
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI067981-03
|
|
Mechanisms of Dinitroaniline Action, Selectivity and Resistance
|
MORRISSETTE, NAOMI
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$327,852
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM059191-08
|
|
Model Studies of Acetyl Coenzyme A Synthase
|
RIORDAN, CHARLES
|
UNIVERSITY OF DELAWARE
|
DE
|
$215,533
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM047296-16
|
|
Novel synthetic pathway for the prymidine of thiamine
|
DOWNS, DIANA
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$288,510
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI043486-10
|
|
Sigma 54 and Vibrio cholerae Pathogenesis
|
KLOSE, KARL
|
UNIVERSITY OF TEXAS SAN ANTONIO
|
TX
|
$164,522
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065786-02
|
|
Stable Carbohydrate Libraries in Infectious Disease
|
LINHARDT, ROBERT
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$384,618
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI046435-08
|
|
New Alphvirus Expression Systems in Mosquitoes
|
OLSON, KENNETH
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$233,469
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI047163-08
|
|
Mechanism of Host Cell Invasion by Microbial Pathogens
|
GHOSH, PARTHO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$206,864
|
|
Emerging Infectious Diseases
|
NIDCR
|
5R01DE016680-05
|
|
Role of KSHV ORF45 in Viral Immune Evasion & Replication
|
ZHU, FANXIU
|
FLORIDA STATE UNIVERSITY
|
FL
|
$241,237
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI062789-03
|
|
Expression and function of the TLRs on T cells
|
TURKA, LAURENCE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$392,769
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI072766-02
|
|
INHIBITORS OF BACTERIAL RNA POLYMERASE: "SWITCH REGION"
|
EBRIGHT, RICHARD
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
NJ
|
$588,112
|
|
Emerging Infectious Diseases
|
NIDDK
|
5K01DK076922-02
|
|
Localized Water Influx During Cryptosporidium Invasion
|
O'HARA, STEVEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$128,223
|
|
Emerging Infectious Diseases
|
FIC
|
5R03TW007421-03
|
|
Identifying Regulation of Cell Cycle Gene Networks in E*
|
SINGH, UPINDER
|
STANFORD UNIVERSITY
|
CA
|
$30,873
|
|
Emerging Infectious Diseases
|
FIC
|
5R21MH077487-02
|
|
HIV Neuropathogenesis in a Cohort of Long-Term Surviving Young Adults in Romania
|
ACHIM, CRISTIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$20,000
|
|
Emerging Infectious Diseases
|
NIMH
|
5R21MH077487-02
|
|
HIV Neuropathogenesis in a Cohort of Long-Term Surviving Young Adults in Romania
|
ACHIM, CRISTIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$116,365
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI054629-04
|
|
The role of NK cells in human M. Tuberculosis infection
|
VANKAYALAPATI, RAMAKRISHNA
|
UNIVERSITY OF TEXAS HLTH CTR AT TYLER
|
TX
|
$255,795
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI047928-08
|
|
Analysis of Mga from the Group A Streptococcus
|
MCIVER, KEVIN
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$282,907
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057885-06
|
|
Attenuated Live and Recombinant Yersinia pestis Vaccines
|
CURTISS, ROY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$594,217
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI045741-09
|
|
Hermes Element Transposition in Mosquitoes
|
ATKINSON, PETER
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
CA
|
$419,895
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI067699-02
|
|
System Dynamics of the Salmonella Virulence Regulatory Network
|
VOIGT, CHRISTOPHER
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$292,831
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM051670-13
|
|
Structural Studies of AIDS-Responsive Drugs
|
CODY, VIVIAN
|
HAUPTMAN-WOODWARD MEDICAL RESEARCH INST
|
NY
|
$382,224
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI037601-14
|
|
Bacterium-ECM interactions during infection by the Lyme disease spirochete
|
LEONG, JOHN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$386,974
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI037606-14
|
|
Molecular Basis of Localized Adherence in E. coli
|
DONNENBERG, MICHAEL
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$276,259
|
|
Emerging Infectious Diseases
|
NIAID
|
5K22AI065828-02
|
|
Small molecule inhibitors of bacterial secretion system
|
LEE, VINCENT
|
UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
|
MD
|
$108,000
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI045738-09
|
|
Evolution and acquistion of drug resistance in MRSA
|
TOMASZ, ALEXANDER
|
ROCKEFELLER UNIVERSITY
|
NY
|
$525,863
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI049360-07
|
|
Regulation of T Cell Activity During Chronic Infections
|
ZAJAC, ALLAN
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$284,490
|
|
Emerging Infectious Diseases
|
NIAID
|
5R37AI028731-19
|
|
Noncarbohydrate Approaches to AntiAIDS Nuleosides
|
LIOTTA, DENNIS
|
EMORY UNIVERSITY
|
GA
|
$324,651
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069192-02
|
|
The Basis for MHC Class II-restricted proteasome-dependent epitopes
|
EISENLOHR, LAURENCE
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$329,586
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064559-03
|
|
Modulation of Host Cell Functions by Coxiella burnetii
|
ROY, CRAIG
|
YALE UNIVERSITY
|
CT
|
$350,420
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064926-04
|
|
Innate Immunity and Bacterial Quorum Sensing
|
GRESHAM, HATTIE
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$348,812
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI061158-04
|
|
Mechanisms of Innate and Adaptive Immunity In HCV
|
NELSON, DAVID
|
UNIVERSITY OF FLORIDA
|
FL
|
$304,514
|
|
Emerging Infectious Diseases
|
NIDDK
|
5R01DK047186-12
|
|
Molecular Mechanisms of Intestinal Atrophy/Hyperplasia
|
HODIN, RICHARD
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$348,707
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064879-03
|
|
Nasal Vaccines: Mode of Action, Composition & Delivery
|
STAATS, HERMAN
|
DUKE UNIVERSITY
|
NC
|
$442,650
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065982-03
|
|
Norovirus Infection of Dendritic Cells and Macrophages
|
VIRGIN, HERBERT
|
WASHINGTON UNIVERSITY
|
MO
|
$317,206
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI046582-09
|
|
Search for novel TB Drug Targets in Lipid Metabolism
|
KOLATTUKUDY, PAPPACHAN
|
UNIVERSITY OF CENTRAL FLORIDA
|
FL
|
$332,534
|
|
Emerging Infectious Diseases
|
NIAID
|
5U01AI069419-02
|
|
Cornell Clinical Trials Unit
|
GULICK, ROY
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$1,184,443
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI061699-04
|
|
Control of CD8+ effector T cell Differentiation
|
REINER, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$361,016
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057770-04
|
|
Mechanisms of Listeria-Specific Immunity
|
HILTBOLD, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$360,044
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI049268-07
|
|
Glycoprotein interactions in paramyxovirus fusion
|
IORIO, RONALD
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$396,692
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059804-05
|
|
Direct Regulation of CD8 T Cells by Interferon gamma
|
SURESH, MARULASIDDAPPA
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$270,678
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI072008-02
|
|
Packaging of Ebola Virus RNA into Budding VLPs
|
HARTY, RONALD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$193,134
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI068922-02
|
|
Molecular mechanism of SIF formation by Salmonella Typhimurium
|
SCHROER, TRINA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$235,995
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM073701-02
|
|
Recognition and phagocytosis of bacteria in Drosophila
|
WU, LOUISA
|
UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
|
MD
|
$292,517
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI047194-08
|
|
Modulation and Resistance of Levamisole Receptor Channels
|
MARTIN, RICHARD
|
IOWA STATE UNIVERSITY
|
IA
|
$275,832
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059136-05
|
|
SARS Reverse Genetics
|
BARIC, RALPH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$271,608
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI063517-04
|
|
Understanding ceftazidime resistance in SHV B-Lactamases
|
BONOMO, ROBERT
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$269,982
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI072346-02
|
|
Single-particle fluorescence studies of viral fusion
|
VAN OIJEN, ANTOINE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$204,440
|
|
Emerging Infectious Diseases
|
NINDS
|
5R01NS034568-13
|
|
STRATEGIES TO ENHANCE GENE TRANSFER TO THE CNS
|
DAVIDSON, BEVERLY
|
UNIVERSITY OF IOWA
|
IA
|
$323,419
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM076710-02
|
|
Mechanism and Inhibition of Bacterial Transglycosylases
|
WALKER, SUZANNE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$468,888
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057450-03
|
|
Chlamydial Manipulation of Host Apoptosis
|
ZHONG, GUANGMING
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$312,913
|
|
Emerging Infectious Diseases
|
NIDA
|
2P30DA011041-11
|
9009
|
INFECTIOUS DISEASES CORE
|
PERLMAN, DAVID
|
NATIONAL DEVELOPMENT & RES INSTITUTES
|
NY
|
$109,870
|
|
Emerging Infectious Diseases
|
NIDA
|
2P30DA011041-11
|
9012
|
DISSEMINATION CORE
|
OSBORNE, ANDREW
|
NATIONAL DEVELOPMENT & RES INSTITUTES
|
NY
|
$181,473
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM060000-07
|
|
Folding and Design of Beta Sheets in Membranes
|
WIMLEY, WILLIAM
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$328,548
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI067449-02
|
|
Prevalence and Epidemiology of Hepatitis E Virus in the United States
|
NELSON, KENRAD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$105,948
|
|
Emerging Infectious Diseases
|
NIAID
|
5R03AI068069-02
|
|
Epidemiology and Clinical Features of Human Coronavirus
|
WILLIAMS, JOHN
|
VANDERBILT UNIVERSITY
|
TN
|
$75,292
|
|
Emerging Infectious Diseases
|
NIDDK
|
5R01DK032034-27
|
|
PORPHYRIN AND CORRINOID BIOSYNTHESIS
|
RAUSHEL, FRANK
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$519,698
|
|
Emerging Infectious Diseases
|
NIAID
|
5R43AI072895-02
|
|
Isolating novel fungi for antibiotic discovery
|
LING, LOSEE
|
NOVOBIOTIC PHARMACEUTICALS, LLC
|
MA
|
$299,258
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI045927-08
|
|
Arenavirus Receptor-Structure/Function Studies
|
OLDSTONE, MICHAEL
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$398,428
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI053138-05
|
|
Novel Ribostamycins and SAR Study of Ring III Aminosugar
|
CHANG, CHENG-WEI
|
UTAH STATE UNIVERSITY
|
UT
|
$129,292
|
|
Emerging Infectious Diseases
|
NINDS
|
5R01NS038604-09
|
|
BIOPHYSICAL MECHANISMS OF PRION PROTEIN PATHOGENICITY
|
SUREWICZ, WITOLD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$310,883
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI072170-02
|
|
Roles of host RNA binding proteins in virus replication
|
NAGY, PETER
|
UNIVERSITY OF KENTUCKY
|
KY
|
$200,124
|
|
Emerging Infectious Diseases
|
NINDS
|
5R01NS040730-09
|
|
The Pathogenesis of Brain Abscess
|
KIELIAN, TAMMY
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$202,248
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069000-03
|
|
Roles for microRNA-122 in hepatitis C virus RNA amplification
|
SARNOW, PETER
|
STANFORD UNIVERSITY
|
CA
|
$295,433
|
|
Emerging Infectious Diseases
|
NHLBI
|
5R01HL080621-03
|
|
Macaque Model and Gene Expression Profiling of SARS
|
KATZE, MICHAEL
|
UNIVERSITY OF WASHINGTON
|
WA
|
$606,132
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI040305-10
|
|
B Cell Superantigens and Immune Regulation
|
SILVERMAN, GREGG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$318,118
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065760-03
|
|
Immune Responses to Biodefense Vaccines Early in Life
|
PASETTI, MARCELA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$353,635
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059118-04
|
|
Generation of Genetically Attenuated Rickettsiae
|
AZAD, ABDU
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$414,654
|
|
Emerging Infectious Diseases
|
NIA
|
1R37AG031220-01
|
|
Towards Therapeutics for Neurodegenerative Diseases
|
PRUSINER, STANLEY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$583,988
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069201-02
|
|
Yeast-Based High-throughput Assays for Proteases of Category A, B, & C Viruses
|
FANG, HONG
|
MICROBIAL NOVOTEQS, INC.
|
TN
|
$404,663
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM079523-02
|
|
The range of recoding and analysis of a 50 nt bypass to probe ribosomal function
|
ATKINS, JOHN
|
UNIVERSITY OF UTAH
|
UT
|
$280,932
|
|
Emerging Infectious Diseases
|
FIC
|
1R03TW007446-01A1
|
|
Invasive Aedes Mosquitoes and Dengue in Brazil
|
LOUNIBOS, LEON
|
UNIVERSITY OF FLORIDA
|
FL
|
$31,254
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065967-04
|
|
Human Monoclonal Antibodies that Bind Botulinum Toxins
|
DESSAIN, SCOTT
|
LANKENAU INSTITUTE FOR MEDICAL RESEARCH
|
PA
|
$375,096
|
|
Emerging Infectious Diseases
|
NINDS
|
5R03NS054666-02
|
|
An improved expression vector to create transgenic mice for prion research.
|
TAMGUNEY, GULTEKIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$77,000
|
|
Emerging Infectious Diseases
|
NIAID
|
5R37AI028724-17
|
|
GENETIC DISSECTION OF TOXOPLASMA GONDII
|
ROOS, DAVID
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$573,854
|
|
Emerging Infectious Diseases
|
NIDA
|
5R01DA012815-09
|
|
Drug Abuse, Substance P and HIV
|
HO, WENZHE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$308,499
|
|
Emerging Infectious Diseases
|
NEI
|
5R01EY010320-15
|
|
The Role of Wolbachia Endobacteria in River Blindness
|
PEARLMAN, ERIC
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$363,992
|
|
Emerging Infectious Diseases
|
NINDS
|
5R01NS051480-03
|
|
Role of the Lysosome in ER Associated Degradation of PrP
|
MASTRIANNI, JAMES
|
UNIVERSITY OF CHICAGO
|
IL
|
$335,359
|
|
Emerging Infectious Diseases
|
NHLBI
|
5R01HL047014-15
|
|
Mechanisms of Clotting Factor Assembly
|
MORRISSEY, JAMES
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$344,250
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069209-03
|
|
Mycobacterial PDIM/PGL: synthesis pathway and inhibition
|
QUADRI, LUIS
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$313,427
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI063233-04
|
|
Host factors in the alphavirus replication complex
|
MACDONALD, MARGARET
|
ROCKEFELLER UNIVERSITY
|
NY
|
$314,396
|
|
Emerging Infectious Diseases
|
FIC
|
1K01TW008005-01
|
|
The Role of Immune Reconstitution Inflammatory Syndrome (IRIS) in Pulmonary Tuber
|
MURDOCH, DAVID
|
DUKE UNIVERSITY
|
NC
|
$112,137
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI059369-04
|
|
Characterizing the Phenotype of Staphylococcal Biofilms
|
ROSS, JULIA
|
UNIVERSITY OF MARYLAND BALT CO CAMPUS
|
MD
|
$358,486
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069087-02
|
|
Detection, diagnosis and treatment of musculoskeletal infection
|
SMELTZER, MARK
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
AR
|
$351,364
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI015035-31
|
|
Permeability of the Epidemic Typhus Rickettsia
|
WINKLER, HERBERT
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$558,107
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI042236-10
|
|
Molecular and Structural Bases of Polymyxin Resistance
|
GROISMAN, EDUARDO
|
WASHINGTON UNIVERSITY
|
MO
|
$205,102
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI062735-04
|
|
Tick polarized T-cell responses and Borrelia infection
|
WIKEL, STEPHEN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$337,184
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI066232-04
|
|
Regulation of memory CD8 T cell development
|
KAECH, SUSAN
|
YALE UNIVERSITY
|
CT
|
$380,205
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069317-02
|
|
Envelope-receptor interactions in Nipah and Hendra virus pathobiology
|
LEE, BENHUR
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$332,651
|
|
Emerging Infectious Diseases
|
NIGMS
|
5R01GM046941-17
|
|
Molecular genetics of Intracellular Protein Transport
|
KAISER, CHRIS
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$331,171
|
|
Emerging Infectious Diseases
|
NIGMS
|
1SC2GM082318-01
|
|
Regulated Assembly of Subcellular Structures in alpha-Proteobacteria
|
CHEN, JOSEPH
|
SAN FRANCISCO STATE UNIVERSITY
|
CA
|
$114,750
|
|
Emerging Infectious Diseases
|
NCI
|
5R01CA115279-04
|
|
Cis and Trans acting factors for HHV8 lytic replication
|
PARI, GREGORY
|
UNIVERSITY OF NEVADA RENO
|
NV
|
$271,536
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI044212-08
|
|
Analysis of L. Pneumophilia Virulence Regulation
|
SWANSON, MICHELE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$241,023
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI057768-04
|
|
Identification of T Cell Antigen For Q Fever Vaccination
|
SAMUEL, JAMES
|
TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR
|
TX
|
$339,862
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI065779-04
|
|
Salmonella anti-influenza DNA & antigen delivery vaccine
|
CURTISS, ROY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$590,554
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI031951-16
|
|
Regulation of Digestion in Blood-Sucking Insects
|
MIESFELD, ROGER
|
UNIVERSITY OF ARIZONA
|
AZ
|
$323,629
|
|
Emerging Infectious Diseases
|
NIAID
|
5U01AI069472-02
|
|
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTU
|
KURITZKES, DANIEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$3,009,817
|
|
Emerging Infectious Diseases
|
NIGMS
|
1SC2AI080867-01
|
|
Engineering Transposon Mobility in Mosquitoes
|
PLEDGER, DAVID
|
TEXAS A&M UNIVERSITY-KINGSVILLE
|
TX
|
$131,260
|
|
Emerging Infectious Diseases
|
NIGMS
|
1SC3GM082343-01
|
|
The role of CD4+ Cell Responses in LCMV Infection
|
MOTHE, BIANCA
|
CALIFORNIA STATE UNIVERSITY SAN MARCOS
|
CA
|
$111,000
|
|
Emerging Infectious Diseases
|
NIAID
|
5U01AI065869-04
|
|
Cell responses to, and proteins exploited by, toxins
|
LORD, JOHN
|
UNIVERSITY OF WARWICK
|
UK
|
$104,680
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI047153-08
|
|
Solid-State NMR of Viral Fusion Peptides and Proteins
|
WELIKY, DAVID
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$270,810
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI055530-04
|
|
Poxvirus regulation of NF-kB: Mechanisms for virulence
|
SHISLER, JOANNA
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$297,445
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI062859-03
|
|
Mucosal Innate Immunity to Salmonella Infection
|
SMITH, KELLY
|
UNIVERSITY OF WASHINGTON
|
WA
|
$334,345
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI072400-02
|
|
RNAi screen to identify host factors involved in Chlamydia pathogenesis
|
DERRE, ISABELLE
|
YALE UNIVERSITY
|
CT
|
$202,689
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI063277-02
|
|
Revascularization of Islets to Treat Type I Diabetes
|
BOTHWELL, ALFRED
|
YALE UNIVERSITY
|
CT
|
$202,689
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI056222-04
|
|
Type 1 Interferon-Regulated T Helper Development
|
FARRAR, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$290,211
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI069142-02
|
|
Immune Mechanisms of HCV Persistence and Pathogenesis
|
SUN, JIAREN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$333,295
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI064611-04
|
|
Receptor-Based Therapeutics for Enterotoxins
|
KRANZ, DAVID
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$296,708
|
|
Emerging Infectious Diseases
|
NIDA
|
5R01DA011598-10
|
|
Nutritional Status In HIV Hispanic Drug Abusers
|
FORRESTER, JANET
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$660,216
|
|
Emerging Infectious Diseases
|
NIAID
|
5R01AI055733-06
|
|
Host Defense Evasion by Fatal Emerging Paramyxoviruses
|
HORVATH, CURT
|
EVANSTON NORTHWESTERN HEALTHCARE
|
IL
|
$247,424
|
|
Emerging Infectious Diseases
|
NIAID
|
5R21AI069276-02
|
|
NKT Cell Recognition of Streptococcus Pneumoniae
|
KRONENBERG, MITCHELL
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
CA
|
$224,128
|
|
